Las Vegas, NV -- (SBWIRE) -- 12/12/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Star Scientific, Inc. (NASDAQ:STSI), Curis, Inc. (NASDAQ:CRIS), Corinthian Colleges Inc (NASDAQ:COCO),Peregrine Pharmaceuticals (NASDAQ:PPHM)
Star Scientific, Inc. (NASDAQ:STSI) managed to keep its fall at -4.65% on above-normal volume of 1.67M shares. The stock settled at $1.23 after floating in a range of $1.21 to $1.34. Its latest price has reached market capitalization of $208.02 million. Its 52-week range has been $1.15 to $3.38. Star Scientific, Inc. (Star Scientific) is engaged in the manufacturing and production of dietary supplements. The Company’s operating subsidiaries manufacture, distribute and sell consumer products and dietary supplements. Its segment includes dietary supplements.
Has STSI Found The Bottom and Ready To Move Up? Find Out Here
Curis, Inc. (NASDAQ:CRIS) traded down on a volume of 1.58 million, higher than its standard daily volume. Shares have dropped-11.19% to $2.46. Over the last twelve months, the stock has lost-19.34% and faced a worst price of $2.45. Curis, Inc. is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies. The Company conducts its research and development programs both internally and through strategic collaborations. Its advanced program is Hedgehog pathway inhibitor program under collaboration with Genentech, Inc., a wholly owned member of the Roche Group.
Has CRIS Found The Bottom And Ready To Gain Momentum? Find Out Here
Corinthian Colleges Inc (NASDAQ:COCO) settled -5.29% lower at $1.61 on above-normal volume of 1.55M shares during the last trading day. The stock has its 12-month high at $2.97 and 52-week low price was $1.61. It traded in a range of $1.61 to $1.74 during the last trading day. Corinthian Colleges, Inc. is a post-secondary education company in the United States and Canada. As of June 30, 2013, the Company had a student enrollment of 81,284 and operated 97 schools in 25 states, and 14 schools in the province of Ontario, Canada. It offers a variety of diploma programs and associate, bachelor's and master's degrees. The Company’s training program areas include healthcare, criminal justice, business, mechanical, trades, and information technology.
Will COCO Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Peregrine Pharmaceuticals (NASDAQ:PPHM) showed no change on high volume, trading at a volume of 1.73M versus its average daily volume of 1.20 million shares. At $1.27, the stock has attained market capitalization of 198.71 million. Peregrine Pharmaceuticals, Inc. (Peregrine) is a biopharmaceutical company developing monoclonal antibodies for the treatment and diagnosis of cancer. The Company's pipeline of investigational monoclonal antibodies is based on two technology platforms, including PS-targeting antibodies and DNA/histone-targeting antibodies. Bavituximab is the Company's therapeutic PS-targeting antibody, which has demonstrated therapeutic potential and represents a new approach to treating cancer. PGN650 is the Company's PS-targeting imaging agent that represents a potential new approach to imaging cancer.
Can PPHM Show a Strong Recovery? Find out in This Research Report
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)